Safe_Trades

$PLTR on historic support

Safe_Trades Updated   
NYSE:PLTR   Palantir Technologies Inc.
Hello traders. Let's get right into it: PLTR has tested the $23-$25 support range multiple times the past few months (about 12) . That level was tested 6 times the past 10 days or so. So far it has been holding like a champ. For that reason I think this is a relatively safe place to start a trade because if that level holds we will most likely see some upside sometime soon (perhaps modestly at first due to fear in the market). If we break below that level we can potentially revisit lower lows.The next support is around the $20-$21 range. Below that there is some support on the $16-$17 range.

I believe this is an optimal entry because you can exit the trade with minimal harm if the price breaks and closes below the support. Additionally, there is bullish hidden divergence between RSI and price and MACD is in oversold territory. Finally, volume is decreasing considerably (though still above average), which means sellers are getting exhausted. If you want to be more conservative you can wait for a MACD crossover and move above the 0 level to place a trade. If you are a long term investor I think this is a good buy opportunity. That support zone is solid like a rock. Let's hope it keeps holding.

Safe trades and good luck!

===If you get anything out of this TA, please hit the like button and/or follow for updates and new publications.===

***The ideas shared here are my opinion, not financial advise to place trades. Please do your own research before buying/selling stocks***
Comment:
PLTR is up 5.5% in the after hour trading. Hopefully it will continue moving up and investors will not unload tomorrow at opening.
Comment:
Nice reversal candle so far. Up over 7%:
Comment:
Despite the continued selloff PLTR is still above the $23-$24 support.
Comment:
That support is proving to be of great importance for PLTR. After all the selloff was done today we managed to move back up and close the week above it!

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.